Article Details

Israeli company announces successful trials of plasma-based COVID-19 drug

Retrieved on: 2021-03-31 14:48:45

Tags for this article:

Click the tags to see associated articles and topics

Israeli company announces successful trials of plasma-based COVID-19 drug. View article details on hiswai:

Excerpt

Kamada added that the product has multiple advantages over convalescent plasma transfusion, such as standardized antibody levels, higher potency ...

Article found on: www.xinhuanet.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo